Previous Article | Next Article ![]()
Journal of Virology, February 1999, p. 1092-1098, Vol. 73, No. 2
Microbiology and Tumor Biology Center,
Received 18 September 1998/Accepted 30 October 1998
Alphavirus expression systems based on suicidal virus particles
carrying recombinant replicons have proven to be a very efficient way
to deliver genes for heterologous protein expression. However, present
strategies for production of such particles have biosafety limitations
due to the generation, by RNA recombination, of replication-proficient viruses (RPVs). Here we describe a new packaging system for Semliki Forest virus (SFV) based on a the use of a two-helper system in which
the capsid and spike proteins of the C-p62-6K-E1 polyprotein are
expressed from two independent RNA molecules. The capsid gene contains
a translational enhancer and therefore that sequence was also
engineered in front of the spike sequence p62-6K-E1. A sequence coding
for the foot-and-mouth disease virus 2A autoprotease was inserted in
frame between the capsid translational enhancer and the spike genes.
This allows production of the spike proteins at high levels with
cotranslational removal of the enhancer sequence and normal
biosynthesis of the spike complex. The autoprotease activity of the
capsid protein was abolished by mutation, further increasing the
biosafety of the system. Cotransfection of cells with both helper RNAs
and an SFV vector replicon carrying the LacZ gene led to production
of recombinant particles with titers of up to 8 × 108 particles per 106 cells. Extensive analysis
failed to demonstrate the presence of any RPVs, emphasizing the high
biosafety of the system based on two-helper RNAs.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Two-Helper RNA System for Production of Recombinant
Semliki Forest Virus Particles
*
Corresponding author. Mailing address: Microbiology and
Tumor Biology Center, Karolinska Institute, Box 280, S-17177 Stockholm, Sweden. Phone: 46-8-457 2550. Fax: 46-8-310848. E-mail:
peter.liljestrom{at}mtc.ki.se.
Journal of Virology, February 1999, p. 1092-1098, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|